'Following completion of the proposed acquisition, Zettaone Technologies will become an associate company of Jubilant Ingrevia,' the company said in a statement.

Zettaone Technologies is an electronics design and manufacturing platform with integrated capabilities in electronics/semicon industry. From R&D, design and prototyping, manufacturing, assembly and box build, the company delivers engineering excellence for aerospace, defence, semi-conductor, automotive, medical and industrial applications.

This acquisition will allow the Company to capitalize on its proven manufacturing and customer-centric capabilities in CDMO space, while further strengthening its engagement with customers across the electronics and semiconductor value chain.

The acquisition is proposed to be completed in two tranches, with the first tranche expected to close by November 2026 and the second tranche is expected to close by September 2027.

Shyam S Bhartia, chairman, Jubilant Ingrevia, and Hari S Bhartia, co-chairman & whole-time director, Jubilant Ingrevia, said: “The proposed investment is aligned with the company's Pinnacle growth strategy and provides a strong platform for its play in electronics development and manufacturing services (EDMS) space.

The transaction will enable the company to deliver an integrated value proposition in electronics and semi-conductor space, leading to long-term and sustainable value creation.'

Jubilant Ingrevia is a leading player in specialty chemicals & CDMO globally, serving pharmaceutical, nutrition, agrochemical, consumer, semiconductor and industrial customers. It offers customised solutions that are innovative, cost effective and conform to global quality standards and has a broad portfolio of 130+ products.

The scrip was up 0.08% to currently trade at Rs 726.50 on the BSE.